Publication:
In Silico Study of 4-Amino Substituted-7-Chloroquinoline Derivatives as Plasmodium Falciparum Lactate Dehydrogenase Inhibitors

dc.contributor.authorRanade, Prasanna
dc.contributor.authorNavale, Dinesh
dc.date.accessioned2025-11-21T07:05:05Z
dc.date.issued2024
dc.description.abstractThe docking between 4-amino substituted-7-chloroquinoline derivatives and Plasmodium falciparum lactate dehydrogenase were carried out. The designed 4-aminosubstitued-7-chloroquinoline derivatives show comparable dock score with chloroquine. The docking study reveals that the binding of 4-amino substituted-7-chloroquinoline derivatives and amino acids in the binding pocket of Plasmodium falciparum lactate dehydrogenase is observed. Predicted ADME properties of designed compounds are in range.
dc.identifier.citationRanade, Prasanna B.; Navale, Dinesh N., Negi, Dheeraj M.; Anware, Ubaidullah A.; Jajoriya, Chhaya C. & Mane, Pooja P. (2024). In silico study of 4-amino substituted-7-chloroquinoline derivatives as Plasmodium falciparum lactate dehydrogenase inhibitors. Indian Journal of Biochemistry and Biophysics, 61(7), 443-953. https://doi.org/10.56042/ijbb.v61i7.953
dc.identifier.doihttps://doi.org/10.56042/ijbb.v61i7.953
dc.identifier.urihttp://dspace.ves.ac.in/handle/123456789/389
dc.language.isoen
dc.publisherIndian Journal of Biochemistry and Biophysics
dc.subjectChemistry
dc.titleIn Silico Study of 4-Amino Substituted-7-Chloroquinoline Derivatives as Plasmodium Falciparum Lactate Dehydrogenase Inhibitors
dc.typeArticle
dcterms.subject1LDG
dcterms.subject4-amino substituted-7-chloroquinolines
dcterms.subjectDocking and ADME
dcterms.subjectMalaria
dcterms.subjectPlasmodium falciparum lactate dehydrogenase
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ranade_Prasanna_Navale_Dinesh_IJBB_2024.pdf
Size:
210.67 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: